ATAD1 and malaria: Passive transfers of anti-MSP1-42 or MSP1-19 monoclonal and polyclonal antibodies have protected against malaria [10], [11], [12], [13], [14], [15]; MSP1-42 or MSP1-19 specific antibodies may act by inhibiting merozoite invasion [9].